Cite

HARVARD Citation

    Macaluso, F. et al. (2018). The real-world effectiveness of vedolizumab on intestinal and articular outcomes in inflammatory bowel diseases. Digestive and liver disease. 50 (7), pp. 675-681. [Online]. 
  
Back to record